Quantcast
Last updated on April 23, 2014 at 17:08 EDT

Latest pharmaceutical industry Stories

2014-03-26 00:22:04

Series A co-led by 5AM Ventures and Lundbeckfond Ventures LEXINGTON, Mass., March 26, 2014 /PRNewswire/ -- scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, announced today that it has closed a $16.0 million Series A venture financing round co-led by 5AM Ventures and Lundbeckfond Ventures. Proceeds from the financing will be used to further develop its first two pharmaceutical products and...

2014-03-25 23:21:59

New patient recruiting and retention eBook features marketing, social media, education, planning, communication, and other tips and strategies from leading clinical trials experts. San Francisco, CA (PRWEB) March 25, 2014 Mosio, an award-winning mobile software company providing solutions in clinical research, health services and other industries, announces the release of its new “Clinical Trials Patient Recruiting and Retention: Tips for Success” eBook. The company has partnered with...

2014-03-25 23:04:25

Experts in industry, research and pharma will discuss complex drug market and regulation. Horsham, Pa. (PRWEB) March 25, 2014 Leaders in biosimilar innovation will provide an in-depth, comparative analysis of the current global debates and trends in biosimilar regulation at the DIA 2014 50th Annual Meeting, from June 15 to 19 at the San Diego Convention Center. The “Trends in Biosimilars Regulation Within Developed and Emerging Markets” session will be held on June 19 at 10:45 a.m....

2014-03-25 23:03:32

The expiration of patent protection for some key drugs will lead to industry restructuring and the adoption of new business models. For this reason, industry research firm IBISWorld has updated its report on the Pharmaceutical Product Manufacturing industry in Australia. Melbourne, Australia (PRWEB) March 26, 2014 The Pharmaceutical Product Manufacturing industry is an important component of the pharmaceutical sector. The major global pharmaceutical groups dominate the local industry,...

2014-03-25 16:26:26

DUBLIN and LAVAL, Quebec, March 25, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Metronidazole 1.3% Vaginal Gel, an antibiotic for the treatment of bacterial vaginosis (BV). Actavis acquired the rights to Metronidazole 1.3% from Valeant Pharmaceuticals International in April 2013. Bacterial vaginosis...

2014-03-25 16:26:21

SD-560 is a Novel Oral Small Molecule for the Potential Treatment of Idiopathic Pulmonary Fibrosis and Other Fibrotic Conditions LA JOLLA, Calif., March 25, 2014 /PRNewswire/ -- Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, today announced the issuance of the following composition of matter and method of treatment patents covering its...

2014-03-25 16:26:17

WASHINGTON, March 25, 2014 /PRNewswire-USNewswire/ -- Legislation (HB 1001, HB 745, SB 1014 and SB 1354) being considered today by Florida lawmakers could increase prescription drug costs by more than $12 billion over the next 10 years for the state's employers, seniors, unions, and consumers, the Pharmaceutical Care Management Association (PCMA) said today. "This legislation would force employers and consumers to pay more for prescription drugs," said PCMA President and CEO Mark Merritt....

2014-03-25 12:25:09

WELLESLEY, Massachusetts, March 25, 2014 /PRNewswire/ -- BCC Research [http://www.bccresearch.com ] (www.bccresearch.com) reveals in its new report, MOBILE HEALTH (MHEALTH) TECHNOLOGIES AND GLOBAL MARKETS [http://www.bccresearch.com/market-research/healthcare/mobile-health-hlc162a.html ], the global mHealth market is projected to grow to nearly $21.5 billion by 2018, with a five-year compound annual growth rate (CAGR) of 54.9%. Europe is the fastest moving segment in this...

2014-03-25 08:28:42

--Company presentation will be webcast/available at www.imprimispharma.com-- SAN DIEGO, March 25, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY), a specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical drug formulations, today announced that Imprimis CEO Mark L. Baum is scheduled to present at the 13(th) Annual Needham Healthcare Conference in New York City on Wednesday, April 9, 2014, at 3:40 p.m. ET....

2014-03-24 23:21:49

The global pharmaceutical membrane filtration market is segmented on the basis of technology, application, and region - http://www.marketsandmarkets.com/Market-Reports/pharmaceutical-membrane-filtration-market-255408031.html. (PRWEB) March 24, 2014 The “Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nan filtration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein Purification, Sterilization, Virus Removal & Water...